Trials / Sponsors / Shi Yuankai
Shi Yuankai
Unknown · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Study of Pembrolizumab Combined With Anlotinib in the First Line Therapy for R/M HNSCC With CPS≥1 Head and Neck Squamous Cell Carcinoma | Phase 2 | 2021-07-18 |
| Unknown | Study of Pembrolizumab in the First Line Therapy for R/M HNSCC in China Head and Neck Squamous Cell Carcinoma | — | 2021-02-04 |
| Unknown | SCT200 Injection in Patients With Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma | Phase 2 | 2018-12-30 |